RS1 gene is a novel prognostic biomarker for lung adenocarcinoma

BACKGROUND: Although it has a poor prognosis, patients with lung adenocarcinoma (LUAD) have a relatively higher 5‐year survival period. Thus, it is necessary to identify effective prognostic markers to evaluate the effect of early treatment. RS1 gene encodes retinoschisin, a key protein in congenita...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tao, Cheng, Guowei, Chen, Ping, Peng, Yue, Liu, Lei, Li, Runze, Qiu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200886/
https://www.ncbi.nlm.nih.gov/pubmed/35569920
http://dx.doi.org/10.1111/1759-7714.14471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200886/
https://www.ncbi.nlm.nih.gov/pubmed/35569920
http://dx.doi.org/10.1111/1759-7714.14471

Ejemplares similares